299 related articles for article (PubMed ID: 22472175)
1. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
2. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
3. Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.
Hung SC; Wu IH; Hsue SS; Liao CH; Wang HC; Chuang PH; Sung SY; Hsieh CL
Mol Pharm; 2010 Dec; 7(6):2312-23. PubMed ID: 21033655
[TBL] [Abstract][Full Text] [Related]
4. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
[TBL] [Abstract][Full Text] [Related]
5. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.
Wolterink S; Moldenhauer G; Fogel M; Kiefel H; Pfeifer M; Lüttgau S; Gouveia R; Costa J; Endell J; Moebius U; Altevogt P
Cancer Res; 2010 Mar; 70(6):2504-15. PubMed ID: 20215505
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
8. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.
Kim S; Park YW; Schiff BA; Doan DD; Yazici Y; Jasser SA; Younes M; Mandal M; Bekele BN; Myers JN
Clin Cancer Res; 2005 Mar; 11(5):1713-21. PubMed ID: 15755992
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of X-linked inhibitor of apoptosis protein suppresses tumorigenesis and enhances chemosensitivity in anaplastic thyroid carcinoma.
Liu Y; Zhang B; Shi T; Qin H
Oncotarget; 2017 Nov; 8(56):95764-95772. PubMed ID: 29221164
[TBL] [Abstract][Full Text] [Related]
13. microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.
Hou Z; Yin H; Chen C; Dai X; Li X; Liu B; Fang X
Mol Med Rep; 2012 Sep; 6(3):501-6. PubMed ID: 22711166
[TBL] [Abstract][Full Text] [Related]
14. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
16. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
Wunderlich A; Fischer M; Schlosshauer T; Ramaswamy A; Greene BH; Brendel C; Doll D; Bartsch D; Hoffmann S
Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
[TBL] [Abstract][Full Text] [Related]
18. BRAF is a therapeutic target in aggressive thyroid carcinoma.
Salvatore G; De Falco V; Salerno P; Nappi TC; Pepe S; Troncone G; Carlomagno F; Melillo RM; Wilhelm SM; Santoro M
Clin Cancer Res; 2006 Mar; 12(5):1623-9. PubMed ID: 16533790
[TBL] [Abstract][Full Text] [Related]
19. Effect of {beta}4 integrin knockdown by RNA interference in anaplastic thyroid carcinoma.
Noh TW; Soung YH; Kim HI; Gil HJ; Kim JM; Lee EJ; Chung J
Anticancer Res; 2010 Nov; 30(11):4485-92. PubMed ID: 21115897
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
